These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 9104814)

  • 1. TRAF-interacting protein (TRIP): a novel component of the tumor necrosis factor receptor (TNFR)- and CD30-TRAF signaling complexes that inhibits TRAF2-mediated NF-kappaB activation.
    Lee SY; Lee SY; Choi Y
    J Exp Med; 1997 Apr; 185(7):1275-85. PubMed ID: 9104814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor necrosis factor (TNF) receptor-associated factor (TRAF)-interacting protein (TRIP) negatively regulates the TRAF2 ubiquitin-dependent pathway by suppressing the TRAF2-sphingosine 1-phosphate (S1P) interaction.
    Park ES; Choi S; Shin B; Yu J; Yu J; Hwang JM; Yun H; Chung YH; Choi JS; Choi Y; Rho J
    J Biol Chem; 2015 Apr; 290(15):9660-73. PubMed ID: 25716317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD30/TNF receptor-associated factor interaction: NF-kappa B activation and binding specificity.
    Lee SY; Lee SY; Kandala G; Liou ML; Liou HC; Choi Y
    Proc Natl Acad Sci U S A; 1996 Sep; 93(18):9699-703. PubMed ID: 8790394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD30 induction of human immunodeficiency virus gene transcription is mediated by TRAF2.
    Tsitsikov EN; Wright DA; Geha RS
    Proc Natl Acad Sci U S A; 1997 Feb; 94(4):1390-5. PubMed ID: 9037063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor necrosis factor receptor-associated factor (TRAF)-1, TRAF-2, and TRAF-3 interact in vivo with the CD30 cytoplasmic domain; TRAF-2 mediates CD30-induced nuclear factor kappa B activation.
    Ansieau S; Scheffrahn I; Mosialos G; Brand H; Duyster J; Kaye K; Harada J; Dougall B; Hübinger G; Kieff E; Herrmann F; Leutz A; Gruss HJ
    Proc Natl Acad Sci U S A; 1996 Nov; 93(24):14053-8. PubMed ID: 8943059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor receptor (TNFR)-associated factor 2A (TRAF2A), a TRAF2 splice variant with an extended RING finger domain that inhibits TNFR2-mediated NF-kappaB activation.
    Brink R; Lodish HF
    J Biol Chem; 1998 Feb; 273(7):4129-34. PubMed ID: 9461607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. I-TRAF is a novel TRAF-interacting protein that regulates TRAF-mediated signal transduction.
    Rothe M; Xiong J; Shu HB; Williamson K; Goddard A; Goeddel DV
    Proc Natl Acad Sci U S A; 1996 Aug; 93(16):8241-6. PubMed ID: 8710854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-kappaB pathway by TRAF-binding TNFRs.
    Hauer J; Püschner S; Ramakrishnan P; Simon U; Bongers M; Federle C; Engelmann H
    Proc Natl Acad Sci U S A; 2005 Feb; 102(8):2874-9. PubMed ID: 15708970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel domain in the CD30 cytoplasmic tail mediates NFkappaB activation.
    Horie R; Aizawa S; Nagai M; Ito K; Higashihara M; Ishida T; Inoue J; Watanabe T
    Int Immunol; 1998 Feb; 10(2):203-10. PubMed ID: 9533448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TNF receptor family member BCMA (B cell maturation) associates with TNF receptor-associated factor (TRAF) 1, TRAF2, and TRAF3 and activates NF-kappa B, elk-1, c-Jun N-terminal kinase, and p38 mitogen-activated protein kinase.
    Hatzoglou A; Roussel J; Bourgeade MF; Rogier E; Madry C; Inoue J; Devergne O; Tsapis A
    J Immunol; 2000 Aug; 165(3):1322-30. PubMed ID: 10903733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ATAR, a novel tumor necrosis factor receptor family member, signals through TRAF2 and TRAF5.
    Hsu H; Solovyev I; Colombero A; Elliott R; Kelley M; Boyle WJ
    J Biol Chem; 1997 May; 272(21):13471-4. PubMed ID: 9153189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The TRAF family of signal transducers mediates NF-kappaB activation by the TRANCE receptor.
    Wong BR; Josien R; Lee SY; Vologodskaia M; Steinman RM; Choi Y
    J Biol Chem; 1998 Oct; 273(43):28355-9. PubMed ID: 9774460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor receptor-associated factor (TRAF) 5 and TRAF2 are involved in CD30-mediated NFkappaB activation.
    Aizawa S; Nakano H; Ishida T; Horie R; Nagai M; Ito K; Yagita H; Okumura K; Inoue J; Watanabe T
    J Biol Chem; 1997 Jan; 272(4):2042-5. PubMed ID: 8999898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD30-dependent degradation of TRAF2: implications for negative regulation of TRAF signaling and the control of cell survival.
    Duckett CS; Thompson CB
    Genes Dev; 1997 Nov; 11(21):2810-21. PubMed ID: 9353251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The involvement of multiple tumor necrosis factor receptor (TNFR)-associated factors in the signaling mechanisms of receptor activator of NF-kappaB, a member of the TNFR superfamily.
    Galibert L; Tometsko ME; Anderson DM; Cosman D; Dougall WC
    J Biol Chem; 1998 Dec; 273(51):34120-7. PubMed ID: 9852070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor activator of NF-kappaB recruits multiple TRAF family adaptors and activates c-Jun N-terminal kinase.
    Kim HH; Lee DE; Shin JN; Lee YS; Jeon YM; Chung CH; Ni J; Kwon BS; Lee ZH
    FEBS Lett; 1999 Jan; 443(3):297-302. PubMed ID: 10025951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anatomy of TRAF2. Distinct domains for nuclear factor-kappaB activation and association with tumor necrosis factor signaling proteins.
    Takeuchi M; Rothe M; Goeddel DV
    J Biol Chem; 1996 Aug; 271(33):19935-42. PubMed ID: 8702708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An atypical tumor necrosis factor (TNF) receptor-associated factor-binding motif of B cell-activating factor belonging to the TNF family (BAFF) receptor mediates induction of the noncanonical NF-kappaB signaling pathway.
    Morrison MD; Reiley W; Zhang M; Sun SC
    J Biol Chem; 2005 Mar; 280(11):10018-24. PubMed ID: 15644327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of nuclear factor kappaB by the CD30 receptor is mediated by TRAF1 and TRAF2.
    Duckett CS; Gedrich RW; Gilfillan MC; Thompson CB
    Mol Cell Biol; 1997 Mar; 17(3):1535-42. PubMed ID: 9032281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the tumor necrosis factor receptor-associated factors 1 and 2 and regulation of the nuclear factor-kappaB antiapoptotic activity in human gliomas.
    Conti A; Ageunnouz M; La Torre D; Cardali S; Angileri FF; Buemi C; Tomasello C; Iacopino DG; D'Avella D; Vita G; Tomasello F
    J Neurosurg; 2005 Nov; 103(5):873-81. PubMed ID: 16304992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.